![MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF](/docs/US/2023-11-09/US20230357297A1/abs.jpg.600x600.jpg)
- 专利标题： MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF
-
申请号： US18355945申请日： 2023-07-20
-
公开(公告)号： US20230357297A1公开(公告)日： 2023-11-09
- 发明人: Tomas Vojkovsky , Kevin Sill , Adam Carie
- 申请人： Bold Therapeutics, Inc.
- 申请人地址： CA Vancouver
- 专利权人： Bold Therapeutics, Inc.
- 当前专利权人： Bold Therapeutics, Inc.
- 当前专利权人地址： CA Vancouver
- 分案原申请号： US17330822 2021.05.26
- 主分类号： C07F15/00
- IPC分类号： C07F15/00 ; A61K33/24 ; A61P35/02 ; A61K47/26 ; A61K47/12 ; A61K9/19 ; A61K9/00 ; A61K33/243
![MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF](/abs-image/US/2023/11/09/US20230357297A1/abs.jpg.150x150.jpg)
摘要：
The present invention relates to the preparation of compositions comprising sodium trans-[tetrachlorobis(1H-indazole)ruthenate (III)]. Synthesis and formulation preparation is detailed. Impurity profiles are also discussed. Compositions herein are useful for anti-cancer applications.
信息查询
